Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inne (Issu GmbH) is a Berlin-based biotech and femtech company that has developed the world's first at-home, saliva-based hormone tracking system. The company's core product, the inne Minilab, utilizes a portable reader and biochemical test strips to measure progesterone levels in real-time, providing women with precise data on their fertile window and reproductive health. Beyond fertility tracking, the company is expanding its diagnostic platform to address contraception and perimenopause management. By combining biochemistry with a personalized mobile application, Inne aims to empower women with actionable insights into their hormonal trends without the need for invasive blood tests or temperature monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inne Beauty.